Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes.

Diabetes Obes Metab · 2026 · PMC12992193 · PMID 41491607

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A previous report 31 showed that imeglimin tended to reduce UACR after 6 months of treatment, although the change did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.